Portfolio company
LimFlow
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
LimFlow develops a minimally invasive system to bypass blocked leg arteries for patients with chronic limb-threatening ischemia to prevent major amputation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
AMT-Medical
AMT-Medical develops a minimally invasive heart bypass system for cardiac surgeons to replace open-heart surgery with catheter-based and laser-assisted procedures.
STENTiT
The company develops biodegradable endovascular implants that promote vascular tissue regeneration to treat patients suffering from cardiovascular diseases like peripheral artery disease.
Intact Vascular
The company develops minimally invasive medical devices for treating peripheral artery disease and post-angioplasty dissections in patients and clinicians.
Nitiloop
Nitiloop develops vascular microcatheters for cardiologists and surgeons to treat chronic total occlusions and other complex lesions within coronary and peripheral vasculature.
Alleviant
Alleviant develops a minimally invasive interatrial shunt system to reduce left atrial pressure for patients suffering from chronic heart failure.
Tulyp Medical
This company develops autonomous pressure-guided perfusion systems to preserve tissue viability and maintain healthy blood flow for patients undergoing vascular surgical procedures.
iCHOR Vascular
This company develops minimally invasive mechanical thrombectomy devices for clinicians to remove blood clots from peripheral arteries and veins.
